BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25125219)

  • 1. Dietary guideline adherence for gastroesophageal reflux disease.
    Kubo A; Block G; Quesenberry CP; Buffler P; Corley DA
    BMC Gastroenterol; 2014 Aug; 14():144. PubMed ID: 25125219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of gastroesophageal reflux disease in a rural Indian population.
    Ghoshal UC; Singh R; Rai S
    Indian J Gastroenterol; 2021 Feb; 40(1):56-64. PubMed ID: 33443640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
    Bakr O; Zhao W; Corley D
    J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease.
    Tosetti C; Savarino E; Benedetto E; De Bastiani R;
    Dig Dis Sci; 2021 May; 66(5):1565-1571. PubMed ID: 32578044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of adults suffering from typical gastroesophageal reflux disease symptoms: contribution of latent class analysis in a European observational study.
    Bruley des Varannes S; Cestari R; Usova L; Triantafyllou K; Alvarez Sanchez A; Keim S; Bergmans P; Marelli S; Grahl E; Ducrotté P
    BMC Gastroenterol; 2014 Jun; 14():112. PubMed ID: 24969728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet.
    Taraszewska A
    Rocz Panstw Zakl Hig; 2021; 72(1):21-28. PubMed ID: 33882662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in northern India.
    Sharma PK; Ahuja V; Madan K; Gupta S; Raizada A; Sharma MP
    Indian J Gastroenterol; 2011 May; 30(3):128-34. PubMed ID: 21061110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals.
    Islami F; Nasseri-Moghaddam S; Pourshams A; Poustchi H; Semnani S; Kamangar F; Etemadi A; Merat S; Khoshnia M; Dawsey SM; Pharoah PD; Brennan P; Abnet CC; Boffetta P; Malekzadeh R
    PLoS One; 2014; 9(2):e89256. PubMed ID: 24586635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.
    Niu CY; Zhou YL; Yan R; Mu NL; Gao BH; Wu FX; Luo JY
    World J Gastroenterol; 2012 Dec; 18(48):7333-40. PubMed ID: 23326142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on lifestyle in patients with gastroesophageal 
reflux disease].
    Yuan L; Tang D; Peng J; Qu N; Yue C; Wang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):558-564. PubMed ID: 28626103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of low-fat and full-fat dairy foods on symptoms of gastroesophageal reflux disease: an exploratory analysis based on a randomized controlled trial.
    Fernando I; Schmidt KA; Cromer G; Burhans MS; Kuzma JN; Hagman DK; Utzschneider KM; Holte S; Kraft J; Vaughan TL; Kratz M
    Eur J Nutr; 2022 Aug; 61(5):2815-2823. PubMed ID: 35294608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force.
    Bhatia SJ; Reddy DN; Ghoshal UC; Jayanthi V; Abraham P; Choudhuri G; Broor SL; Ahuja V; Augustine P; Balakrishnan V; Bhasin DK; Bhat N; Chacko A; Dadhich S; Dhali GK; Dhawan PS; Dwivedi M; Goenka MK; Koshy A; Kumar A; Misra SP; Mukewar S; Raju EP; Shenoy KT; Singh SP; Sood A; Srinivasan R
    Indian J Gastroenterol; 2011 May; 30(3):118-27. PubMed ID: 21792655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach.
    Kaltenbach T; Crockett S; Gerson LB
    Arch Intern Med; 2006 May; 166(9):965-71. PubMed ID: 16682569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Night-time symptoms and their impact on sleep in patients with gastroesophageal reflux disease who have a partial response to proton pump inhibitors: a qualitative patient interview study.
    Rydén A; Martin M; Halling K; Niklasson A
    Patient; 2013; 6(4):307-14. PubMed ID: 23990378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.
    Kahrilas PJ; Howden CW; Wernersson B; Denison H; Nuevo J; Gisbert JP
    Aliment Pharmacol Ther; 2013 May; 37(10):1005-10. PubMed ID: 23557078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.
    Ortiz V; Ponce M; Fernández A; Martínez B; Ponce JL; Garrigues V; Ponce J
    Obesity (Silver Spring); 2006 Apr; 14(4):696-700. PubMed ID: 16741272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
    Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.
    Nason KS; Wichienkuer PP; Awais O; Schuchert MJ; Luketich JD; O'Rourke RW; Hunter JG; Morris CD; Jobe BA
    Arch Surg; 2011 Jul; 146(7):851-8. PubMed ID: 21768433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
    Kindt S; Imschoot J; Tack J
    Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.